Attovia Therapeutics, Inc.
ATTO
$19.49
$0.311.59%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -18.66M | -15.15M | |||
| Total Depreciation and Amortization | 242.00K | 143.00K | |||
| Total Amortization of Deferred Charges | -- | 364.00K | |||
| Total Other Non-Cash Items | 814.00K | 485.00K | |||
| Change in Net Operating Assets | -541.00K | 28.00K | |||
| Cash from Operations | -18.14M | -14.13M | |||
| Capital Expenditure | -288.00K | -1.79M | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 22.77M | -27.50M | |||
| Cash from Investing | 22.49M | -29.29M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 11.00K | 45.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | 142.19M | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -1.25M | -345.00K | |||
| Cash from Financing | -1.24M | 141.89M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 3.10M | 98.47M | |||